NewSpring, Tecum Capital, Leedon Park and PNC Provide Growth Investment in Spirit Pharmaceuticals

April 27, 2021

An investor group led by NewSpring Mezzanine, alongside Tecum Capital, Leedon Park Capital and PNC Bank provided a growth capital injection into Spirit Pharmaceuticals LLC, backing CEO and founder Ajoy Joshi. The funding will support the Long Island-based private-label developer, packager and distributor of over-the-counter pharmaceutical products as it expands capacity (two additional facilities, 11 packaging lines) and deepens relationships with big-box retailers, medical distributors and e-commerce customers.

Buyers
NewSpring Mezzanine (NewSpring Capital), Tecum Capital (Tecum Capital Partners), Leedon Park Capital LLC, PNC Bank (PNC Financial Services Group)
Targets
Spirit Pharmaceuticals LLC
Industry
Pharmaceuticals
Location
New York, United States
Transaction Type
Growth capital

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.